Literature DB >> 18317277

Early surgical treatment for epilepsy.

John T Langfitt1, Samuel Wiebe.   

Abstract

PURPOSE OF REVIEW: To review recent evidence that can assist clinicians facing the challenging question of when to offer brain surgery for epilepsy. RECENT
FINDINGS: The most robust recent evidence pertains to temporal lobe epilepsy. We focus on this syndrome to assess the main issues pertaining to early surgery, which include natural history and effectiveness of medication, risks associated with continued seizures, effectiveness and risks of surgery, and cognitive outcomes in relation to timing of surgery.
SUMMARY: The evidence for performing surgery earlier is persuasive but incomplete. Recent evidence indicates that intractability, and therefore consideration for surgery, does not develop at a uniform time in surgical candidates, and that late remissions with medical treatment are not rare. Factors that may suggest sustained intractability include a larger number of medications tried, longer duration of seizures, history of status epilepticus, mental retardation, and nonidiopathic epilepsy. Adequate prospective studies, however, need to address this important question systematically. The evidence regarding morbidity, quality of life, mortality, social and cognitive function suggests that earlier surgery may be beneficial, but prospective controlled studies with standardized interventions and outcomes will be required to derive firm conclusions.

Entities:  

Mesh:

Year:  2008        PMID: 18317277     DOI: 10.1097/WCO.0b013e3282f47931

Source DB:  PubMed          Journal:  Curr Opin Neurol        ISSN: 1350-7540            Impact factor:   5.710


  9 in total

1.  Paediatric epilepsy surgery: making the best of a tough situation.

Authors:  Anne T Berg
Journal:  Brain       Date:  2014-11-12       Impact factor: 13.501

2.  Magnetic resonance imaging connectivity for the prediction of seizure outcome in temporal lobe epilepsy.

Authors:  Victoria L Morgan; Dario J Englot; Baxter P Rogers; Bennett A Landman; Ahmet Cakir; Bassel W Abou-Khalil; Adam W Anderson
Journal:  Epilepsia       Date:  2017-04-27       Impact factor: 5.864

3.  Epilepsy surgery: a broken bridge between utility and utilization.

Authors:  Mohamad Koubeissi
Journal:  Epilepsy Curr       Date:  2012-09       Impact factor: 7.500

4.  The brain connectome as a personalized biomarker of seizure outcomes after temporal lobectomy.

Authors:  Leonardo Bonilha; Jens H Jensen; Nathaniel Baker; Jesse Breedlove; Travis Nesland; Jack J Lin; Daniel L Drane; Amit M Saindane; Jeffrey R Binder; Ruben I Kuzniecky
Journal:  Neurology       Date:  2015-04-08       Impact factor: 9.910

5.  Referral pattern for epilepsy surgery after evidence-based recommendations: a retrospective study.

Authors:  Zulfi Haneef; John Stern; Sandra Dewar; Jerome Engel
Journal:  Neurology       Date:  2010-08-24       Impact factor: 9.910

6.  Longitudinal and cross-sectional analysis of atrophy in pharmacoresistant temporal lobe epilepsy.

Authors:  B C Bernhardt; K J Worsley; H Kim; A C Evans; A Bernasconi; N Bernasconi
Journal:  Neurology       Date:  2009-02-25       Impact factor: 9.910

7.  New-onset partial epilepsy in adults.

Authors:  Lynn Liu; J Craig Henry
Journal:  Curr Treat Options Neurol       Date:  2009-07       Impact factor: 3.598

Review 8.  Bridging the Gap between Evidence and Practice for Adults with Medically Refractory Temporal Lobe Epilepsy: Is a Change in Funding Policy Needed to Stimulate a Shift in Practice?

Authors:  Alireza Mansouri; Abdulrahman Aldakkan; Magda J Kosicka; Jean-Eric Tarride; Taufik A Valiante
Journal:  Epilepsy Res Treat       Date:  2015-12-07

9.  Structural Brain Network Abnormalities and the Probability of Seizure Recurrence After Epilepsy Surgery.

Authors:  Nishant Sinha; Yujiang Wang; Nádia Moreira da Silva; Anna Miserocchi; Andrew W McEvoy; Jane de Tisi; Sjoerd B Vos; Gavin P Winston; John S Duncan; Peter N Taylor
Journal:  Neurology       Date:  2020-12-22       Impact factor: 9.910

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.